2024

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB::NOTCH1 fusions with unfavorable outcome
Te Vrugt M, Wessolowski J, Randau G, Alfert A, Mueller S, Scholten K, Sopalla C, Lanvers-Kaminsky C, Hotfilder M, Lamp F, Damm-Welk C, Luedersen J, Escherich G, Zur Stadt U, Behrmann L, Woessmann W, Oschlies I, Marzi M, Zimmermann M, Burkhardt B
BLOOD. 2024;144(13):1412-1417.

Health-Related Quality of Life and Mental Health of Parents of Children with Pediatric Abdominal Tumors
Zierke K, Boettcher M, Behrendt P, Najem S, Zapf H, Reinshagen K, Wößmann W, Boettcher J
CHILDREN-BASEL. 2024;11(8):.

2023

Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma
Au-Yeung R, Padilla L, Zimmermann M, Reinke S, Oschlies I, Escherich G, Woessmann W, Burkhardt B, Klapper W
LEUKEMIA. 2023;37(2):488-491.

Health-Related Quality of Life and Mental Health of Children with Embryonal Abdominal Tumors
Behrendt P, Boettcher M, Zierke K, Najem S, Zapf H, Reinshagen K, Wößmann W, Boettcher J
CHILDREN-BASEL. 2023;10(10):.

Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
Beishuizen A, Mellgren K, Andrés M, Auperin A, Bacon C, Bomken S, Burke G, Burkhardt B, Brugieres L, Chiang A, Damm-Welk C, d'Amore E, Horibe K, Kabickova E, Khanam T, Kontny U, Klapper W, Lamant L, Le Deley M, Loeffen J, Macintyre E, Mann G, Meyer-Wentrup F, Michgehl U, Minard-Colin V, Mussolin L, Oschlies I, Patte C, Pillon M, Reiter A, Rigaud C, Roncery L, Salaverria I, Simonitsch-Klupp I, Uyttebroeck A, Verdu-Amoros J, Williams D, Woessmann W, Wotherspoon A, Wrobel G, Zimmermann M, Attarbaschi A, Turner S
LANCET HAEMATOL. 2023;10(3):e213-e224.

Surgical Experience Affects the Outcome of Central Venous Access Catheter Implantation in Children: A Retrospective Cohort Study
Fritsch L, Le M, Elrod J, Wössmann W, Vincent D, Reinshagen K, Boettcher M
J PEDIAT HEMATOL ONC. 2023;45(2):57-62.

Correction: Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT
Hauch R, Hinrichs M, Ruhwald R, Schrum J, Rutkowski S, Woessmann W, Winkler B
KLIN PADIATR. 2023;235(3):e1-e2.

Impact of COVID-19 Related Restrictions on Infections in Children with Cancer or after Hematopoietic SCT: A Monocentric, Retrospective Study
Hauch R, Hinrichs M, Ruhwald R, Schrum J, Rutkowski S, Woessmann W, Winkler B
KLIN PADIATR. 2023;235(3):159-166.

Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation
Heinz A, Calkoen F, Derbich A, Miltner L, Seitz C, Doering M, Braun C, Atar D, Schumm M, Heubach F, Arendt A, Schulz A, Schuster F, Meisel R, Strahm B, Finke J, Heineking B, Stetter S, Silling G, Stachel D, Gruhn B, Debatin K, Foell J, Schulte J, Woessmann W, Mauz-Körholz C, Tischer J, Feuchtinger T, Handgretinger R, Lang P
HAEMATOLOGICA. 2023;108(8):2080-2090.

Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma
Knörr F, Schellekens K, Schoot R, Landman-Parker J, Teltschik H, Förster J, Riquelme A, Huitema A, Van Eijkelenburg N, Beishuizen A, Zwaan C, Woessmann W, Van der Lugt J
HAEMATOLOGICA. 2023;108(5):1442-1446.

Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma - Response
Knörr F, Woessmann W
BRIT J HAEMATOL. 2023;200(1):107-108.

Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents
Rigaud C, Knörr F, Brugières L, Woessmann W
BEST PRACT RES CL HA. 2023;36(1):101444.

Generalized Infantile Myofibromatosis with Extensive Small Bowel Involvement in a Neonate
Schubert J, Wößmann W, Königs I, Clauditz T, Kordes U, Reinshagen K
Z GEBURTSH NEONATOL. 2023;227(3):231-235.

2022

Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age
Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, Gökbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G
NAT COMMUN. 2022;13(1):.

Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
Damm-Welk C, Lovisa F, Contarini G, Lüdersen J, Carraro E, Knörr F, Förster J, Zimmermann M, Sala A, Vinti L, Tondo A, Pillon M, Woessmann W, Mussolin L
CANCERS. 2022;14(7):.

PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
Garces de Los Fayos Alonso I, Zujo L, Wiest I, Kodajova P, Timelthaler G, Edtmayer S, Zrimšek M, Kollmann S, Giordano C, Kothmayer M, Neubauer H, Dey S, Schlederer M, Schmalzbauer B, Limberger T, Probst C, Pusch O, Högler S, Tangermann S, Merkel O, Schiefer A, Kornauth C, Prutsch N, Zimmerman M, Abraham B, Anagnostopoulos J, Quintanilla-Martinez L, Mathas S, Wolf P, Stoiber D, Staber P, Egger G, Klapper W, Woessmann W, Look T, Gunning P, Turner S, Moriggl R, Lagger S, Kenner L
MOL CANCER. 2022;21(1):172.

ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant
Holsten T, Bronsema A, Sturm D, Sahm F, Rutkowski S, Ulrich S, Wößmann W, Kordes U
PEDIATR BLOOD CANCER. 2022;69(8):.

Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
Möker P, Zur Stadt U, Zimmermann M, Alawi M, Mueller S, Finger J, Knörr F, Riquelme A, Oschlies I, Klapper W, Bradtke J, Burkhardt B, Woessmann W, Damm-Welk C
LEUKEMIA. 2022;36(9):2343-2346.

2021

Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents
Attarbaschi A, Carraro E, Ronceray L, Andrés M, Barzilai-Birenboim S, Bomken S, Brugières L, Burkhardt B, Ceppi F, Chiang A, Csoka M, Fedorova A, Jazbec J, Kabickova E, Loeffen J, Mellgren K, Miakova N, Moser O, Osumi T, Pourtsidis A, Rigaud C, Uyttebroeck A, Woessmann W, Pillon M
LEUKEMIA. 2021;35(2):534-549.

Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents
Au-Yeung R, Richter J, Iaccarino I, Abramov D, Bacon C, Balagué O, d'Amore E, Simonitsch-Klupp I, Hebeda K, Nakazawa A, Oschlies I, Kontny U, Woessmann W, Burkhardt B, Klapper W
PEDIATR BLOOD CANCER. 2021;68(11):.

Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
Burkhardt B, Taj M, Garnier N, Minard-Colin V, Hazar V, Mellgren K, Osumi T, Fedorova A, Myakova N, Verdu-Amoros J, Andres M, Kabickova E, Attarbaschi A, Chiang A, Bubanska E, Donska S, Hjalgrim L, Wachowiak J, Pieczonka A, Uyttebroeck A, Lazic J, Loeffen J, Buechner J, Niggli F, Csoka M, Krivan G, Palma J, Burke G, Beishuizen A, Koeppen K, Mueller S, Herbrueggen H, Woessmann W, Zimmermann M, Balduzzi A, Pillon M
CANCERS. 2021;13(9):.

Neuro-meningeal relapse in anaplastic large-cell lymphoma: incidence, risk factors and prognosis - a report from the European intergroup for childhood non-Hodgkin lymphoma
Del Baldo G, Abbas R, Woessmann W, Horibe K, Pillon M, Burke A, Beishuizen A, Rigaud C, Le Deley M, Lamant L, Brugières L
BRIT J HAEMATOL. 2021;192(6):1039-1048.

Integrative genomic analysis of pediatric T- cell lymphoblastic lymphoma reveals candidates of clinical significance
Khanam T, Sandmann S, Seggewiss J, Ruether C, Zimmermann M, Norvil A, Bartenhagen C, Randau G, Mueller S, Herbrüggen H, Hoffmann P, Herms S, Wei L, Wöste M, Wünsch C, Gowher H, Oschlies I, Klapper W, Woessmann W, Dugas M, Burkhardt B
BLOOD. 2021;137(17):2347-2359.

Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma
Knörr F, Zimmermann M, Attarbaschi A, Kabickova E, Maecker-Kolhoff B, Ruf S, Kühnle I, Ebinger M, Garthe A, Simonitsch-Klupp I, Oschlies I, Klapper W, Burkhardt B, Wößmann W
HAEMATOLOGICA. 2021;106(12):3232-3235.

Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target
Larose H, Prokoph N, Matthews J, Schlederer M, Högler S, Alsulami A, Ducray S, Nuglozeh E, Fazaludeen F, Elmouna A, Ceccon M, Mologni L, Gambacorti-Passerini C, Hoefler G, Lobello C, Pospisilova S, Janikova A, Woessmann W, Damm-Welk C, Zimmermann M, Federova A, Malone A, Smith O, Wasik M, Inghirami G, Lamant L, Blundell T, Klapper W, Merkel O, Burke G, Mian S, Ashankyty I, Kenner L, Turner S
HAEMATOLOGICA. 2021;106(6):1693-1704.

Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
Liang H, Costanza M, Prutsch N, Zimmerman M, Gurnhofer E, Montes-Mojarro I, Abraham B, Prokoph N, Stoiber S, Tangermann S, Lobello C, Oppelt J, Anagnostopoulos I, Hielscher T, Pervez S, Klapper W, Zammarchi F, Silva D, Garcia K, Baker D, Janz M, Schleussner N, Fend F, Pospíšilová Š, Janiková A, Wallwitz J, Stoiber D, Simonitsch-Klupp I, Cerroni L, Pileri S, de Leval L, Sibon D, Fataccioli V, Gaulard P, Assaf C, Knörr F, Damm-Welk C, Woessmann W, Turner S, Look A, Mathas S, Kenner L, Merkel O
NAT COMMUN. 2021;12(1):.

Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group
Moser O, Zimmermann M, Meyer U, Klapper W, Oschlies I, Schrappe M, Attarbaschi A, Mann G, Niggli F, Spix C, Kontny U, Klingebiel T, Reiter A, Burkhardt B, Woessmann W
HAEMATOLOGICA. 2021;106(5):1390-1400.

Minimal Disease Monitoring in Pediatric Non-Hodgkin's Lymphoma: Current Clinical Application and Future Challenges
Mussolin L, Damm-Welk C, Pillon M, Woessmann W
CANCERS. 2021;13(8):.

Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK)
Nemes K, Bens S, Kachanov D, Teleshova M, Hauser P, Simon T, Tippelt S, Woessmann W, Beck O, Flotho C, Grigull L, Driever P, Schlegel P, Khurana C, Hering K, Kolb R, Leipold A, Abbink F, Gil-Da-Costa M, Benesch M, Kerl K, Lowis S, Marques C, Graf N, Nysom K, Vokuhl C, Melchior P, Kröncke T, Schneppenheim R, Kordes U, Gerss J, Siebert R, Furtwängler R, Frühwald M
EUR J CANCER. 2021;142:112-122.

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Pearson A, Barry E, Mossé Y, Ligas F, Bird N, de Rojas T, Zimmerman Z, Wilner K, Woessmann W, Weiner S, Weigel B, Venkatramani R, Valteau D, Trahair T, Smith M, Singh S, Selvaggi G, Scobie N, Schleiermacher G, Richardson N, Park J, Nysom K, Norga K, Merino M, McDonough J, Matloub Y, Marshall L, Lowe E, Lesa G, Irwin M, Karres D, Gajjar A, Doz F, Fox E, DuBois S, Donoghue M, Casanova M, Caron H, Buenger V, Bradford D, Blanc P, Barone A, Reaman G, Vassal G
EUR J CANCER. 2021;157:198-213.

Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma
Reutter K, Sandmann S, Rohde J, Müller S, Wöste M, Khanam T, Michgehl U, Klapper W, Wößmann W, Seggewiß J, Lenz G, Dugas M, Burkhardt B
LEUKEMIA. 2021;35(2):639-643.

The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
van Tilburg C, Pfaff E, Pajtler K, Langenberg K, Fiesel P, Jones B, Balasubramanian G, Stark S, Johann P, Blattner-Johnson M, Schramm K, Dikow N, Hirsch S, Sutter C, Grund K, von Stackelberg A, Kulozik A, Lissat A, Borkhardt A, Meisel R, Reinhardt D, Klusmann J, Fleischhack G, Tippelt S, von Schweinitz D, Schmid I, Kramm C, von Bueren A, Calaminus G, Vorwerk P, Graf N, Westermann F, Fischer M, Eggert A, Burkhardt B, Wößmann W, Nathrath M, Hecker-Nolting S, Frühwald M, Schneider D, Brecht I, Ketteler P, Fulda S, Koscielniak E, Meister M, Scheer M, Hettmer S, Schwab M, Tremmel R, Øra I, Hutter C, Gerber N, Lohi O, Kazanowska B, Kattamis A, Filippidou M, Goemans B, Zwaan C, Milde T, Jäger N, Wolf S, Reuss D, Sahm F, von Deimling A, Dirksen U, Freitag A, Witt R, Lichter P, Kopp-Schneider A, Jones D, Molenaar J, Capper D, Pfister S, Witt O
CANCER DISCOV. 2021;11(11):2764-2779.

2020

Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma
Attarbaschi A, Abla O, Arias Padilla L, Beishuizen A, Burke G, Brugières L, Bruneau J, Burkhardt B, d'Amore E, Klapper W, Kontny U, Pillon M, Taj M, Turner S, Uyttebroeck A, Woessmann W, Mellgren K
PEDIATR BLOOD CANCER. 2020;67(8):e28416.

Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group
Au-Yeung R, Arias Padilla L, Zimmermann M, Oschlies I, Siebert R, Woessmann W, Burkhardt B, Klapper W
BRIT J HAEMATOL. 2020;190(5):753-763.

Quantification of minimal disseminated disease by quantitative PCR and digital PCR for NPM-ALK as prognostic factor in children with anaplastic large cell lymphoma
Damm-Welk C, Kutscher N, Zimmermann M, Attarbaschi A, Schieferstein J, Knörr F, Oschlies I, Klapper W, Woessmann W
HAEMATOLOGICA. 2020;105(8):2141-2149.

Tuberculosis-Associated HLH in an 8-Month-Old Infant: A Case Report and Review
Hauch H, Skrzypek S, Woessmann W, Lehmberg K, Ehl S, Speckmann C, Schneck E, Koerholz D, Jux C, Neuhäuser C
FRONT PEDIATR. 2020;8:.

Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence
Herbrueggen H, Mueller S, Rohde J, Arias Padilla L, Moericke A, Attarbaschi A, Zimmermann M, Ratei R, Brueggemann M, Siebert R, Goehring G, Schlegelberger B, Bradtke J, Klapper W, Woessmann W, Burkhardt B
LEUKEMIA. 2020;34(3):942-946.

Register und Studien in der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) – Welchen Beitrag leisten sie zum Fortschritt?
Klingebiel T, Jürgens H, Glauche I, Gnekow A, Kandels D, Woessmann W, Schneider D, Suttorp M
KLIN PADIATR. 2020;232(3):124-135.

Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial
Knörr F, Brugières L, Pillon M, Zimmermann M, Ruf S, Attarbaschi A, Mellgren K, Burke G, Uyttebroeck A, Wróbel G, Beishuizen A, Aladjidi N, Reiter A, Woessmann W
J CLIN ONCOL. 2020;38(34):3999-4009.

Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial
Mussolin L, Le Deley M, Carraro E, Damm-Welk C, Attarbaschi A, Williams D, Burke A, Horibe K, Nakazawa A, Wrobel G, Mann G, Csóka M, Uyttebroeck A, Fernández-Delgado Cerdá R, Beishuizen A, Mellgren K, Burkhardt B, Klapper W, Turner S, D'Amore E, Lamant L, Reiter A, Woessmann W, Brugières L, Pillon M
CANCERS. 2020;12(10):.

IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
Prokoph N, Probst N, Lee L, Monahan J, Matthews J, Liang H, Bahnsen K, Montes-Mojarro I, Karaca Atabay E, Sharma G, Malik V, Larose H, Forde S, Ducray S, Lobello C, Wang Q, Luan S, Pospisilova S, Gambacorti-Passerini C, Burke A, Pervez S, Attarbaschi A, Janikova A, Pacquement H, Landman-Parker J, Lambilliotte A, Schleiermacher G, Klapper W, Jauch R, Woessmann W, Vassal G, Kenner L, Merkel O, Mologni L, Chiarle R, Brugieres L, Geoerger B, Barbieri I, Turner S
BLOOD. 2020;136(14):1657-1669.

ATM activity in T cells is critical for immune surveillance of lymphoma in vivo
Riabinska A, Lehrmann D, Jachimowicz R, Knittel G, Fritz C, Schmitt A, Geyer A, Heneweer C, Wittersheim M, Frenzel L, Torgovnick A, Wiederstein J, Wunderlich C, Ortmann M, Paillard A, Wößmann W, Borkhardt A, Burdach S, Hansmann M, Rosenwald A, Perner S, Mall G, Klapper W, Merseburg A, Krüger M, Grüll H, Persigehl T, Wunderlich F, Peifer M, Utermöhlen O, Büttner R, Beleggia F, Reinhardt H
LEUKEMIA. 2020;34(3):771-786.

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy
Woessmann W, Zimmermann M, Meinhardt A, Müller S, Hauch H, Knörr F, Oschlies I, Klapper W, Niggli F, Kabickova E, Attarbaschi A, Reiter A, Burkhardt B
BLOOD. 2020;135(14):1124-1132.

Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning
Wustrau K, Greil J, Sykora K, Albert M, Burkhardt B, Lang P, Meisel R, Wössmann W, Beier R, Schulz A, Bader P, Chada M, Kühl J, Schlegel P, Speckmann C, Gruhn B, Seidel M, Wawer A, Ozga A, Janka G, Ehl S, Müller I, Lehmberg K
PEDIATR BLOOD CANCER. 2020;67(9):e28523.

2019

Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents
Attarbaschi A, Abla O, Ronceray L, Bansil S, Bomken S, Burkhardt B, Ceppi F, Chiang A, Dave H, Fedorova A, Henry M, Jazbec J, Kabickova E, Kotecha R, Lazic J, Loeffen J, Miakova N, Osumi T, Pillon M, Pourtsidis A, Rigaud C, Tamamyan G, Tandon S, Uyttebroeck A, Verdu-Amoros J, Woessmann W, Wrobel G, Giulino-Roth L
BLOOD ADV. 2019;3(24):4291-4297.

CD38 is not expressed in pediatric ALK-positive anaplastic large cell lymphoma
Au-Yeung R, Burkhardt B, Woessmann W, Klapper W
PEDIATR BLOOD CANCER. 2019;66(3):e27541.

Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency
Aydin S, Freeman A, Al-Herz W, Al-Mousa H, Arnaout R, Aydin R, Barlogis V, Belohradsky B, Bonfim C, Bredius R, Chu J, Ciocarlie O, Doğu F, Gaspar H, Geha R, Gennery A, Hauck F, Hawwari A, Hickstein D, Hoenig M, Ikinciogullari A, Klein C, Kumar A, Ifversen M, Matthes S, Metin A, Neven B, Pai S, Parikh S, Picard C, Renner E, Sanal Ö, Schulz A, Schuster F, Shah N, Shereck E, Slatter M, Su H, van Montfrans J, Woessmann W, Ziegler J, Albert M
J ALLER CL IMM-PRACT. 2019;7(3):848-855.

Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL
Babor F, Peters C, Manser A, Glogova E, Sauer M, Pötschger U, Ahlmann M, Cario G, Feuchtinger T, Gruhn B, Güngör T, Kremens B, Lang P, Mezger M, Müller I, Mytilineos J, Oevermann L, Pichler H, Scherenschlich N, Schuster F, Siepermann M, Stachel D, Strahm B, Wössmann W, Escherich G, Zimmermann M, Schrappe M, Borkhardt A, Eckert C, Bader P, Uhrberg M, Meisel R
BONE MARROW TRANSPL. 2019;54(11):1847-1858.

Minimal Disseminated and Minimal Residual Disease in Pediatric Non-Hodgkin Lymphoma
Mussolin L, Damm-Welk C, Wößmann W
2019. Non-Hodgkin´s Lymphoma in Children and Adolescence. Abla O, Attarbaschi A (eds.). 1. ed. Cham: Springer, 119 - 129.

Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP
Pichler H, Lawitschka A, Glogova E, Willasch A, von Luettichau I, Lehrnbecher T, Matthes-Martin S, Lang P, Bader P, Sykora K, Schrum J, Kremens B, Ehlert K, Albert M, Kuhlen M, Meisel R, Guengoer T, Strahm B, Gruhn B, Schulz A, Woessmann W, Poetschger U, Peters C
AM J HEMATOL. 2019;94(8):880-890.

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
Singh V, Werner S, Schwalm S, Lennerz V, Ruf S, Stadler S, Hackstein H, Reiter A, Wölfel T, Damm-Welk C, Woessmann W
ONCOIMMUNOLOGY. 2019;8(9):e1625688.

Rare mature B-cell lymphomas in children and adolescents
Woessmann W, Quintanilla-Martinez L
HEMATOL ONCOL. 2019;37 Suppl 1:53-61.

Risikofaktoren für einen gemischten Chimerismus nach Stammzelltransplantation mit Treosulfan- oder Melphalanbasierter Konditionierung bei Kindern und Jugendlichen mit primärer Hämophagozytischer Lymphohistiozytose
Wustrau K, Albert M, Bader P, Beier R, Burkhardt B, Chada M, Greil J, Gruhn B, Kühl J, Lang P, Meisel R, Schulz A, Seidel M, Speckmann C, Sykora K, Wawer A, Wößmann W, Ozga A, Janka-Schaub G, Ehl S, Müller I, Lehmberg K
2019. Monatsschrift Kinderheilkunde > Ausgabe 7/2018 . 646-647.

2018

Lmo2 expression defines tumor cell identity during T-cell leukemogenesis
García-Ramírez I, Bhatia S, Rodríguez-Hernández G, González-Herrero I, Walter C, González de Tena-Dávila S, Parvin S, Haas O, Woessmann W, Stanulla M, Schrappe M, Dugas M, Natkunam Y, Orfao A, Domínguez V, Pintado B, Blanco O, Alonso-López D, De Las Rivas J, Martín-Lorenzo A, Jiménez R, García Criado F, García Cenador M, Lossos I, Vicente-Dueñas C, Borkhardt A, Hauer J, Sánchez-García I
EMBO J. 2018;37(14):.

Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Knörr F, Damm-Welk C, Ruf S, Singh V, Zimmermann M, Reiter A, Woessmann W
HAEMATOLOGICA. 2018;103(3):477-485.

Epitope mapping of anti-ALK antibodies in children with anaplastic large cell lymphoma
Knörr F, Weber S, Singh V, Pulford K, Reiter A, Woessmann W, Damm-Welk C
CLIN IMMUNOL. 2018;195:77-81.

Characterization and diagnostic application of genomic fusion sequences in anaplastic large-cell lymphoma
Krumbholz M, Woessmann W, Zierk J, Seniuk D, Ceppi P, Zimmermann M, Singh V, Metzler M, Damm-Welk C
ONCOTARGET. 2018;9(41):26543-26555.

Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial
Kuhlen M, Bader P, Sauer M, Albert M, Gruhn B, Güngör T, Kropshofer G, Lang P, Lawitschka A, Metzler M, Pentek F, Rossig C, Schlegel P, Schrappe M, Schrum J, Schulz A, Schwinger W, von Stackelberg A, Strahm B, Suttorp M, Luettichau I, Wößmann W, Borkhardt A, Meisel R, Poetschger U, Glogova E, Peters C
BRIT J HAEMATOL. 2018;183(1):104-109.

Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma
Makarova O, Oschlies I, Müller S, Ruf S, Zimmermann M, Niggli F, Attarbaschi A, Kabickova E, Klapper W, Woessmann W, Burkhardt B
BRIT J HAEMATOL. 2018;182(5):735-739.

Course of anti-ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma
Mussolin L, Pillon M, Zimmermann M, Carraro E, Basso G, Knoerr F, Woessmann W, Damm-Welk C
BRIT J HAEMATOL. 2018;182(5):733-735.

Duodenocolonic Fistula As A Rare Complication of Intestinal Burkitt Lymphoma in a Three-Year-Old Boy
Okuda K, Laass M, Schuchardt K, Lange B, Knöfler R, Fitze G, Woessmann W, Suttorp M
KLIN PADIATR. 2018;230(3):138-141.

CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case series
Ruf S, Hebart H, Hjalgrim L, Kabickova E, Lang P, Steinbach D, Schwabe G, Woessmann W
PEDIATR BLOOD CANCER. 2018;65(6):e27003.

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
Schleussner N, Merkel O, Costanza M, Liang H, Hummel F, Romagnani C, Durek P, Anagnostopoulos I, Hummel M, Jöhrens K, Niedobitek A, Griffin P, Piva R, Sczakiel H, Woessmann W, Damm-Welk C, Hinze C, Stoiber D, Gillissen B, Turner S, Kaergel E, von Hoff L, Grau M, Lenz G, Dörken B, Scheidereit C, Kenner L, Janz M, Mathas S
LEUKEMIA. 2018;32(9):1994-2007.

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
Stadler S, Singh V, Knörr F, Damm-Welk C, Woessmann W
CANCERS. 2018;10(4):.

Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents
Verdú-Amorós J, Woessmann W, Maecker-Kolhoff B, Schulz A, Strauss G, Bein G, Hackstein H
TRANSFUSION. 2018;58(11):2495-2500.

IG- neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
Wagener R, López C, Kleinheinz K, Bausinger J, Aukema S, Nagel I, Toprak U, Seufert J, Altmüller J, Thiele H, Schneider C, Kolarova J, Park J, Hübschmann D, Murga Penas E, Drexler H, Attarbaschi A, Hovland R, Kjeldsen E, Kneba M, Kontny U, de Leval L, Nürnberg P, Oschlies I, Oscier D, Schlegelberger B, Stilgenbauer S, Wössmann W, Schlesner M, Burkhardt B, Klapper W, Jaffe E, Küppers R, Siebert R
BLOOD. 2018;132(21):2280-2285.

Risk factors for mixed chimerism after stem cell transplantation with treosulfan or melphalan based conditioning regimens in children and adolescents with primary hemophagocytic lymphohistocytosis
Wustrau K, Albert M, Bader P, Beier R, Burkhardt B, Chada M, Greil J, Gruhn B, Kühl J, Lang P, Meisel R, Schulz A, Seidel M, Speckmann C, Sykora K, Wawer A, Wößmann W, Ozga A, Ehl S, Müller I, Lehmberg K
2018. Bone Marrow Transplantation (2018) Abstracts Collection. .

2015

Immunotherapy with the trifunctional anti-CD20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent CD20-positive B cell malignancies
Schuster F, Stanglmaier M, Woessmann W, Winkler B, Siepermann M, Meisel R, Schlegel P, Hess J, Lindhofer H, Borkhardt A, Buhmann R
BRIT J HAEMATOL. 2015;169(1):90-102.

Letzte Aktualisierung aus dem FIS: 24.12.2024 - 03:52 Uhr